文献速递白血病

RNA结合蛋白IGF2BP1通过调控HOXB4、MYB和ALDH1A1维持白血病干细胞特性

RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.
PubMed 文献 · Leukemia · 2019-11-25

该研究在多种髓系、B系和T系白血病细胞系中,采用功能获得与缺失系统、CLIP和PAR-CLIP技术,评估IGF2BP1对白血病干细胞特性的调控作用。研究发现遗传或化学抑制IGF2BP1可降低白血病细胞致瘤性、促进髓系分化、增加细胞死亡并增敏化疗药物,其作用通过自我更新关键调控因子HOXB4和MYB及醛脱氢酶ALDH1A1实现。

要点

  • 抑制IGF2BP1降低白血病细胞致瘤性并促进髓系分化
  • IGF2BP1通过HOXB4、MYB和ALDH1A1调控干细胞特性
  • 遗传或化学抑制IGF2BP1可增敏白血病细胞对化疗药物

核心结论

  • IGF2BP1通过转录和代谢因子调控多条干性通路以维持白血病干细胞特性。

研究设计与样本

  • 在髓系、B系和T系白血病细胞系中采用功能获得与缺失系统、CLIP和PAR-CLIP技术评估IGF2BP1作用。

主要发现

  • 遗传或化学抑制IGF2BP1降低白血病细胞致瘤性、促进髓系分化、增加细胞死亡并增敏化疗药物。
  • IGF2BP1通过自我更新关键调控因子HOXB4和MYB及醛脱氢酶ALDH1A1影响白血病细胞增殖和致瘤潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an oncofetal protein expressed in various cancers including leukemia. In this study, we assessed the role of IGF2BP1 in orchestrating leukemia stem cell properties. Tumor-initiating potential, sensitivity to chemotherapeutic agents, and expression of cancer stem cell markers were assessed in a panel of myeloid, B-, and T-cell leukemia cell lines using gain- and loss-of-function systems, cross-linking immunoprecipitation (CLIP), and photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP) techniques. Here, we report that genetic or chemical inhibition of IGF2BP1 decreases leukemia cells' tumorigenicity, promotes myeloid differentiation, increases leukemia cell death, and sensitizes leukemia cells to chemotherapeutic drugs. IGF2BP1 affects proliferation and tumorigenic potential of leukemia cells through critical regulators of self-renewal HOXB4 and MYB and through regulation of expression of the aldehyde dehydrogenase, ALDH1A1. Our data indicate that IGF2BP1 maintains leukemia stem cell properties by regulating multiple pathways of stemness through transcriptional and metabolic factors.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Elcheva IA, Wood T, Chiarolanzio K, et al. RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1. Leukemia. 2019. PMID: 31768017. doi:10.1038/s41375-019-0656-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。